Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive

Carmen V Leitner1, Ines A Ederer1, Michela de Martino1

  • 1Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.

The Journal of Urology
|February 3, 2016
PubMed
Summary

Recurrence and progression rates in nonmuscle invasive bladder cancer decrease over time. Established risk factors lose prognostic impact, but Bacillus Calmette-Guérin shows long-term protection against progression.